Showing results (1451-1460 of 2,232) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|September 6, 2008
What can be expected from nuclear medicine tomorrow?Jacques Barbet, Françoise Kraeber-Bodéré, Jean-François ChatalCancer Biotherapy & Radiopharmaceuticals|August 24, 2005
Vaccine of engineered tumor cells secreting stromal cell-derived factor-1 induces T-cell dependent antitumor responsesMeiqing Shi, Siguo Hao, Liping Su, et al.Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
A phase I study of an anti-GD3 monoclonal antibody, KW-2871, in patients with metastatic melanomaAndres Forero, Jatin Shah, Ronda Carlisle, et al.Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
Preoperative localization of parathyroid adenomas with technetium-99m methoxyisobutylisonitrile imaging: relationship with P-glycoprotein expression, oxyphilic cell content, and tumoral tissue volumeBulent Turgut, Sahande Elagoz, Taner Erselcan, et al.Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
Administration of a conditionally replicative oncolytic canine adenovirus in normal dogsBruce F Smith, David T Curiel, Vladimir V Ternovoi, et al.Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacityZhenmin Ye, Zhuang Chen, Amer Sami, et al.Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Targeting the virus with radioimmunotherapy in virus-associated cancersEkaterina Dadachova, Xing-Guo Wang, Arturo CasadevallCancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Lym-1-induced apoptosis of non-Hodgkin's lymphomas produces regression of transplanted tumorsNan Zhang, Leslie A Khawli, Peisheng Hu, et al.Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
The genotoxic effects in lymphocyte cultures of children treated with radiosynovectomy by using yttrium-90 citrate colloidCuneyt Turkmen, Sukru Ozturk, Seher N Unal, et al.Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Preparation of TH227-labeled radioimmunoconjugates, assessment of serum stability and antigen binding abilityRoy H Larsen, Jorgen Borrebaek, Jostein Dahle, et al.Pageof 224